Article

Important eye health issues examined in Ophthalmology journal

Three studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

San Francisco-Three studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

From the Women's Health Study (WHS) it was determined that women who took vitamin E supplements had rates of cataract development comparable with women who did not take such supplements. The 39,876 professional women aged 45 or more took 600 IU of vitamin E (every other day) and 100 mg of aspirin (every day) in this 10-year randomized, controlled study.

A study in an Asian population linked good eyesight to living longer. According to the study, led by Tien Yin Wong, MD, PhD, 10% of the 1,232 Chinese people living in Singapore died and the death rate was three times higher for people with 20/40 vision.

Evidence has been found to support the theory that low cerebrospinal fluid (CSF) pressure may be a significant contributor to optic nerve damage in glaucoma. Results showed that between 1996 and 2007, 28 patients with primary open-angle glaucoma who had CSF samples taken by lumbar punctures had significantly lower pressure than controls.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.